This collaboration marks an important step for RetinaLyze as Medicontur CZ becomes the official distributor of RetinaLyze products in the Czech market.
The partnership combines RetinaLyze’s cutting-edge AI technology for eye screenings with Medicontur CZ’s established presence in the Czech ophthalmology sector. By joining forces, the two companies aim to improve access to advanced eye care solutions and enhance the early detection of eye diseases throughout the region.
RetinaLyze has revolutionized the eye care industry with its state-of-the-art software, which has already performed over six million screenings across Europe, identifying more than 70,000 potential eye disease cases. The software is widely used in hospitals, eye clinics, optical chains, and optometrists' stores, providing fast and accurate screenings that help healthcare professionals detect conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma at an early stage.
Medicontur CZ s.r.o. is a leading supplier of intraocular lenses and ophthalmological materials in the Czech Republic. The company offers a comprehensive range of ophthalmological devices and instruments from renowned manufacturers such as TOPCON, Katalyst Surgical, and Medone. With a strong commitment to quality and customer service, Medicontur CZ is a trusted partner in the Czech ophthalmology market.
The distribution agreement between RetinaLyze and Medicontur CZ leverages the strengths of both companies to deliver innovative eye care solutions to healthcare providers in the Czech Republic. This partnership will facilitate the integration of RetinaLyze’s AI technology into existing ophthalmology practices, providing professionals with powerful tools to enhance patient care.
“We are excited to partner with Medicontur CZ to bring RetinaLyze’s advanced screening solutions to the Czech market,” said Teddy Birch Petersen, CEO of RetinaLyze. “This collaboration will allow us to reach more healthcare providers and help improve the early detection and treatment of eye diseases in the region.”
“Partnering with RetinaLyze aligns with our commitment to providing our customers with the most advanced ophthalmological technologies available,” said Miroslava Chladková, CEO of Medicontur Cz. “We are proud to offer RetinaLyze’s innovative solutions to our clients and look forward to a successful collaboration.”
For more information about RetinaLyze and its products, please visit https://retinalyze.com. To learn more about Medicontur CZ and its offerings, visit https://medicontur.cz/.
Teddy Birch Petersen
CEO
RetinaLyze System A/S
tbp@retinalyze.com
Miroslava Chladková
CEO
Medicontur CZ s.r.o.
mchladkova@medicontur.com
RetinaLyze System A/S is a Denmark-based software company that provides artificial intelligence and telemedicine solutions for the optometry and healthcare industry. Its innovative software platform is designed to assist healthcare professionals in the early detection of eye diseases, enhancing patient outcomes through timely intervention.
Medicontur CZ s.r.o. is a leading supplier of ophthalmological products and services in the Czech Republic. Specializing in intraocular lenses and devices from top manufacturers, Medicontur CZ is dedicated to providing high-quality products and exceptional service to its customers.
